Use of recombinant factor VIIa (NovoSeven) in the treatment of two patients with type III von Willebrand's disease and an inhibitor against von Willebrand factor - Ciavarella, N; Schiavoni, M; Valenzano, E (Haemostasis, 1996)
et al.